Skip to content

The effect of transcranial direct current stimulation on upper limb motor function in stroke patients

The effect of the combined Transcranial Direct Current Stimulation with Task- Oriented Training on Electroencephalographic Biomarkers and involved upper limb motor function in hemiparesis post stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140222016680N9
Enrollment
36
Registered
2022-10-08
Start date
2022-10-30
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unilateral ischemic stroke. Cerebral infarction, unspecified

Interventions

Intervention 1: Intervention group: In this group, transcranial Direct Current Stimulation (tDCs) along with Task-Oriented Training are given for three weeks, 5 sessions per week, and each session for

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Having a first unilateral ischemic stroke as confirmed by the MRI or CT-Scan At least 6 months have passed since the unilateral stroke Having the ability to walk for at least 10 meter (with or without cane) Having motor dysfunction in upper limb with a degree of recovery equal or more than 4 according to the recovery stages of Brunnstrom Having a score equal or above 26 in the "Montreal Cognitive Assessment"

Exclusion criteria

Exclusion criteria: Having moderate to severe depression (a score of 19 or higher on the "Beck depression scale") Received Botox in the previous 6 months (to enter the study, patients must not have received Botox in the past six months) Having a contracture in the wrist and fingers of the affected side Having other neurological disorders such as Parkinson, Multiple Sclerosis and etc. Having a thalamic stroke or central pain syndrome (Dejerine Roussy Syndrome) Pain in the affected shoulder (having a score of less than 12 based on the Pain Assessment section of the "Fugle-Meyer assessment" of the upper extremity) Using drugs that affect the central nervous system Having pace maker or other stimulation or ferromagnetic implants Having a history of Seizures in the last two years and taking anticonvulsant drugs during one month before the enrollment in the current study Pregnancy unwillingness and lack of cooperation to continue the treatment Having serious and persistent skin complications or sleep and concentration disorders due to stimulation with tDCs Not completing the treatment period or occurrence of an accident that affects the motor function or brain activity

Design outcomes

Primary

MeasureTime frame
Electroencephalography parameters include "Absolute power" and "Relative power" and "Average frequency" within each frequency subband (delta, theta, alpha, beta and gamma). Timepoint: before treatment, after treatment (15th session), and 3 months later. Method of measurement: EEG recording.

Secondary

MeasureTime frame
Upper limb motor function ability by the "Wolf Motor Function Test". Timepoint: before treatment, after treatment (15th session), and 3 months later. Method of measurement: "Wolf Motor Function Test".;Upper limb motor function by the upper extremity part of the "Fugl-Meyer Assessment". Timepoint: before treatment, after treatment (15th session), and 3 months later. Method of measurement: Upper Extremity part of the "Fugl-Meyer Assessment".;Patient's ability to handle objects of different sizes, weights and shapes. Timepoint: before treatment, after treatment (15th session), and 3 months later. Method of measurement: "Action Research Arm Test".

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShohreh Noorizadeh Dehkordi

Iran University of Medical Sciences

noorizadeh.sh@iums.ac.ir+98 21 2222 7124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026